If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:635702-64-6
Source:Taiwan
Qualifications:USDMF/-/-/-/-
| Name | Pazopanib Hydrochloride/Pazopanib |
|---|---|
| Chinese name | 盐酸帕唑帕尼/培唑帕尼 |
| Cas Number | 635702-64-6 |
| Source | Taiwan |
| Qualifications | USDMF/-/-/-/- |
Pazopanib hydrochloride is a multi-target tyrosine kinase inhibitor that inhibits angiogenesis. It was approved by the FDA on October 19, 2009 for the treatment of advanced kidney cancer.
Hot Tags: pazopanib hydrochloride/pazopanib api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Linagliptin API, Vardenafil API, Ticagrelor API, Troxagliptin Succinate API, Perindopril Arginine API, Temozolomide API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
